LAVA Therapeutics
LVTX
LVTX
19 hedge funds and large institutions have $10.6M invested in LAVA Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.25%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
3
Increased
4
Reduced
4
Closed
4
Calls
$28K
Puts
–
Net Calls
+$28K
Net Calls Change
-$40K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$61.8K |
| 2 |
RC
Rangeley Capital
New Canaan,
Connecticut
|
+$35.7K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$18.8K |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$13.2K |
| 5 |
LDNAM
Lepercq De Neuflize Asset Management
New York
|
+$10.6K |
Top Sellers
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$61.5K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$30.9K |
| 3 |
Two Sigma Investments
New York
|
-$30.8K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.63K |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.65K |
